Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pureos Bioventures
Zurich, Switzerland
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Pureos Bioventures is not a drug developer but a dedicated life-science venture capital fund investing in private preclinical and clinical-stage biotech companies developing innovative therapeutics for severe diseases across oncology, immunology, ophthalmology, rare diseases, neuroscience, infectious disease and fibrosis.[1][2]
- Modalities
- AntibodyAntibody-drug conjugateMonoclonal antibodyRNA therapyAntisense oligonucleotideCell therapyGene therapymRNA-based drugsVaccineSmall moleculeRadiopharmaceutical
- Industry
- Investors
02
Partnerships
BaseLaunch (Basel-based incubator and accelerator)[1][2]
Beyond the preview
Go deeper on Pureos Bioventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pureos Bioventures.